EP 2708560 A4 20150114 - ANTIBODY SPECIFICALLY RECOGNISING TRANSFERRIN RECEPTOR
Title (en)
ANTIBODY SPECIFICALLY RECOGNISING TRANSFERRIN RECEPTOR
Title (de)
ANTIKÖRPER ZUM SPEZIFISCHEN NACHWEIS VON TRANSFERRIN-REZEPTOREN
Title (fr)
ANTICORPS RECONNAISSANT SPÉCIFIQUEMENT UN RÉCEPTEUR DE LA TRANSFERRINE
Publication
Application
Priority
- JP 2011104007 A 20110509
- JP 2012061676 W 20120507
Abstract (en)
[origin: EP2708560A1] An object of present invention is to provide a complete human anti-human TfR antibody, which specifically recognizes human TfR, inhibits the survival or growth of cancer cells that highly express TfR, and has no immunogenicity to humans. The present invention provides an antibody which specifically reacts with human TfR, wherein the antibody comprises any one of the amino acid sequences shown in SEQ ID NOS: 1-3, 7-9, 13-15, 19-21, 25-27, 31-33, 37-39, 43-45, 49-51, 55-57, 61-63, 67-69, 73-75, 79-81, 85-87, 91-93, 97-99, 103-105, 109-111, and 115-117, as each of a heavy chain first complementarity determining region (VH CDR1), a heavy chain second complementarity determining region (VH CDR2), and a heavy chain third complementarity determining region (VH CDR3).
IPC 8 full level
C07K 16/30 (2006.01); A61K 39/395 (2006.01); A61P 35/02 (2006.01); C07K 16/28 (2006.01); C12N 15/09 (2006.01); C12P 21/08 (2006.01)
CPC (source: EP US)
A61P 35/02 (2017.12 - EP); C07K 16/2881 (2013.01 - EP US); C07K 16/30 (2013.01 - US)
Citation (search report)
- [X] WO 2005121179 A2 20051222 - RAVEN BIOTECHNOLOGIES INC [US], et al
- [XI] M-A. POUL ET AL.: "Selection of tumor-specific internalizing human antibodies from phage libraries.", JOURNAL OF MOLECULAR BIOLOGY, vol. 301, 2000, pages 1149 - 1161, XP004461688
- [X] S. WHITE ET AL.: "Combinations of anti-transferrin receptor monoclonal antibodies inhibit human tumor cell growth in vitro and in vivo: Evidence for synergistic antiproliferative effects.", CANCER RESEARCH, vol. 50, no. 19, 1 October 1990 (1990-10-01), pages 6295 - 6301, XP008073808
- [X] D. BROOKS ET AL.: "Phase Ia trial of murine immunoglobulin A antitransferrin receptor antibody 42/6.", CLINICAL CANCER RESEARCH, vol. 1, November 1995 (1995-11-01), pages 1259 - 1265, XP000887102
- See references of WO 2012153707A1
Designated contracting state (EPC)
AL AT BE BG CH CY CZ DE DK EE ES FI FR GB GR HR HU IE IS IT LI LT LU LV MC MK MT NL NO PL PT RO RS SE SI SK SM TR
DOCDB simple family (publication)
EP 2708560 A1 20140319; EP 2708560 A4 20150114; CA 2835603 A1 20121115; CN 103534272 A 20140122; CN 103534272 B 20160511; HK 1193833 A1 20141003; JP 5980202 B2 20160831; JP WO2012153707 A1 20140731; US 2014114054 A1 20140424; US 9598496 B2 20170321; WO 2012153707 A1 20121115
DOCDB simple family (application)
EP 12781761 A 20120507; CA 2835603 A 20120507; CN 201280022819 A 20120507; HK 14107189 A 20140715; JP 2012061676 W 20120507; JP 2013514005 A 20120507; US 201214116714 A 20120507